Jae-Sung Kim Selected Research

Death Domain Receptors

11/2022	Arctigenin induces caspase-dependent apoptosis in FaDu human pharyngeal carcinoma cells.
2/2020	25-Hydroxycholesterol Induces Death Receptor-mediated Extrinsic and Mitochondria-dependent Intrinsic Apoptosis in Head and Neck Squamous Cell Carcinoma Cells.
1/2019	Reversine induces caspase-dependent apoptosis of human osteosarcoma cells through extrinsic and intrinsic apoptotic signaling pathways.
5/2017	Licochalcone-E induces caspase-dependent death of human pharyngeal squamous carcinoma cells through the extrinsic and intrinsic apoptotic signaling pathways.
4/2015	Berberine induces FasL-related apoptosis through p38 activation in KB human oral cancer cells.
5/2014	Induction of apoptosis by diphenyldifluoroketone in osteogenic sarcoma cells is associated with activation of caspases.
2/2014	Licochalcone A induces apoptosis in KB human oral cancer cells via a caspase-dependent FasL signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jae-Sung Kim Research Topics

Disease

73	Neoplasms (Cancer) 11/2023 - 10/2002
29	Rectal Neoplasms (Rectal Cancer) 01/2023 - 10/2002
16	Prostatic Neoplasms (Prostate Cancer) 09/2023 - 11/2012
15	Ischemia 12/2022 - 10/2002
15	Breast Neoplasms (Breast Cancer) 08/2022 - 01/2010
14	Inflammation (Inflammations) 11/2022 - 11/2011
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 03/2013
12	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2003
11	Mitochondrial Diseases (Mitochondrial Disease) 01/2024 - 11/2004
10	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2010
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 10/2009
8	Osteoarthritis 01/2021 - 12/2013
7	Squamous Cell Carcinoma of Head and Neck 05/2022 - 01/2015
7	Reperfusion Injury 01/2021 - 06/2004
7	Mouth Neoplasms (Oral Cancer) 10/2017 - 01/2013
6	Infections 09/2020 - 12/2006
6	Pain (Aches) 11/2015 - 10/2010
6	Laryngeal Neoplasms (Laryngeal Cancer) 02/2015 - 07/2010
6	Necrosis 01/2013 - 10/2002
5	Body Weight (Weight, Body) 11/2023 - 03/2015
5	Carcinoma (Carcinomatosis) 11/2022 - 04/2003
5	Hepatocellular Carcinoma (Hepatoma) 07/2022 - 09/2008
5	Head and Neck Neoplasms (Head and Neck Cancer) 06/2021 - 07/2011
5	Carcinogenesis 07/2019 - 02/2014
5	Hypoxia (Hypoxemia) 10/2018 - 12/2006
4	Adenocarcinoma 01/2023 - 10/2009
4	Edema (Dropsy) 06/2018 - 09/2017
3	Parkinson Disease (Parkinson's Disease) 01/2024 - 04/2005
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 03/2013
3	Liver Diseases (Liver Disease) 11/2023 - 12/2011
3	Colitis 01/2023 - 12/2021
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 10/2016
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2022 - 04/2014
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2021 - 10/2009
3	Tuberculosis (Tuberculoses) 05/2021 - 01/2017
3	Sepsis (Septicemia) 04/2020 - 01/2016
3	Osteosarcoma (Osteogenic Sarcoma) 01/2019 - 01/2014
3	Brain Neoplasms (Brain Tumor) 02/2018 - 11/2015
3	Fatty Liver 01/2017 - 08/2016
3	Intervertebral Disc Degeneration 09/2013 - 12/2010
2	Osteoporosis 01/2023 - 01/2023
2	Fatigue 06/2022 - 07/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 09/2012

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2002
11	CytokinesIBA 07/2021 - 10/2010
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2012
8	CaspasesIBA 11/2022 - 01/2013
7	Death Domain ReceptorsIBA 11/2022 - 02/2014
7	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2021 - 12/2004
7	MicroRNAs (MicroRNA)IBA 06/2018 - 07/2011
6	Phosphotransferases (Kinase)IBA 01/2020 - 06/2004
6	Small Interfering RNA (siRNA)IBA 01/2019 - 02/2014
6	Adenosine Triphosphate (ATP)IBA 01/2017 - 10/2002
5	Hormones (Hormone)IBA 01/2020 - 03/2016
5	Caspase 3 (Caspase-3)IBA 05/2018 - 01/2013
4	InterferonsIBA 12/2022 - 11/2011
4	Peptides (Polypeptides)IBA 11/2022 - 01/2016
4	DAPIIBA 11/2022 - 02/2014
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2019 - 02/2014
4	CarrageenanIBA 06/2018 - 09/2017
4	Morphine (MS Contin)FDA LinkGeneric 11/2015 - 12/2006
4	BuffersIBA 04/2012 - 06/2004
3	Sirtuin 1IBA 01/2024 - 03/2016
3	Prostate-Specific Antigen (Semenogelase)IBA 06/2023 - 01/2014
3	CholesterolIBA 04/2023 - 01/2020
3	25-hydroxycholesterolIBA 01/2023 - 01/2020
3	InflammasomesIBA 01/2023 - 11/2020
3	Caspase 9IBA 11/2022 - 02/2014
3	CateninsIBA 01/2022 - 04/2014
3	Therapeutic UsesIBA 12/2021 - 10/2018
3	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 09/2012
3	Interleukin-6 (Interleukin 6)IBA 07/2021 - 11/2011
3	Carcinoembryonic AntigenIBA 04/2020 - 02/2011
3	LipidsIBA 01/2020 - 07/2013
3	ErbB Receptors (EGF Receptor)IBA 07/2019 - 07/2006
3	Cytochromes c (Cytochrome c)IBA 05/2018 - 10/2002
3	LigandsIBA 01/2018 - 01/2013
3	KetorolacIBA 11/2015 - 01/2011
3	Pregabalin (Lyrica)FDA Link 11/2015 - 01/2011
3	Celecoxib (Celebrex)FDA Link 11/2015 - 01/2011
3	IronIBA 07/2015 - 11/2008
3	3' Untranslated Regions (3' UTR)IBA 04/2014 - 02/2014
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2012 - 10/2002
3	HEPESIBA 04/2012 - 06/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2011 - 01/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 10/2013
2	Protons (Proton)IBA 07/2022 - 01/2016

Therapy/Procedure

50	Radiotherapy 11/2023 - 04/2003
23	Chemoradiotherapy 10/2021 - 07/2010
20	Therapeutics 01/2022 - 12/2010
16	Neoadjuvant Therapy 01/2023 - 10/2002
15	Drug Therapy (Chemotherapy) 10/2021 - 04/2003
8	Prostatectomy (Retropubic Prostatectomy) 10/2022 - 10/2015
7	Transplantation 12/2022 - 12/2011
7	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 08/2022 - 02/2015
4	Adjuvant Radiotherapy 12/2017 - 01/2013
3	Proctectomy 01/2021 - 09/2008
3	Molecular Targeted Therapy 01/2020 - 01/2016
3	Adjuvant Chemotherapy 01/2015 - 02/2013
2	Oral Administration 01/2023 - 01/2020